US outlines exemption steps for pharmaceutical tariffs
MLex summary: The US Commerce Department's Bureau of Industry and Security submitted rules and guidelines for exemptions from a 100 percent pharmaceutical tariff under Section 232, outlining how eligible companies can...To view the full article, register now.
Already a subscriber? Click here to view full article